Dermatology CRO Market
Dermatology CRO Market Analysis by Type (Drug Discovery, Clinical, Preclinical), by Service (Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/Assurance, Bio-statistics), by Region - Global Forecast 2022 to 2032
Analysis of Dermatology CRO market covering 30+ countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Dermatology CRO Market Growth Overview for 2022 to 2032
The Dermatology CRO Market size was valued at US$ 4.0 Billion in 2021, and is projected to reach US$ 12.8 Billion by 2032, with a projected compound annual growth rate (CAGR) of 9.1% during the forecast period from 2023 to 2032.
Global market is segmented into various sub-types, including drug discovery, clinical, preclinical. Among all the types, Clinical type dermatology CRO is expected to be the highest revenue grossing service, accounting for an absolute dollar opportunity of nearly US$ 3.5 Billion during 2022 to 2032.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue of Dermatology CRO from 2017 to 2021 Compared to Demand Outlook for 2021 to 2031
As per the Dermatology CRO industry research by Fact.MR - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the Dermatology CRO industry increased at around 7.8% CAGR, wherein, countries such as the U.S., U.K., China, Japan and South Korea held significant share in the global market.
The rising need for topical dermatological drugs to treat acne, such as anti-inflammatory, anti-infective, local anaesthetics, cleansers, and emollients, is a primary driver of the market. Increased awareness of skin disorders, a high need for quick detection, and a growth in the frequency of skin cancer and other skin ailments are all propelling the business ahead. Owing to this, Dermatology CRO market is projected to grow at a CAGR of 9.1% over the coming 10 years.
- The Dermatology CRO market is estimated to reach a valuation of US$ 1.7 Bn in 2022 as the worldwide revenues was up by 8.6% year-over-year. Because of the introduction of virtual clinical trials and government measures to maintain the disrupted supply chains in healthcare, the market for dermatological contract research organisations (CRO) was mostly unscathed by the COVID 19’s ramifications. Fact.MR estimates that Dermatology CRO revenue will grow 2.4X from 2022 to 2032, reaching nearly US$ 4.3 Bn in 2032.
- The revenue through clinical dermatology type is projected to garner a CAGR of around 10% during 2022 to 2032.
- Dermatology CRO revenue through clinical monitoring will account for majority share, owing to countries’ focus on dermatological medications.
What is Making Dermatology CRO an Essential Component?
The market is primarily driven by the need for topical dermatological medications such as anti-infectives, anti-inflammatory, local anesthetics, emollients, and cleansers to cure acne. Over the forecast period, increased incidences of skin diseases over the world are expected to boost dermatology CRO market growth.
Acne is the most prevalent skin disease in the United States, with up to 50 Mn people affected each year, according to the American Academy of Dermatology Association. One out of every ten people suffers with atopic dermatitis at some time in their lives. In the United States, 7.5 Mn individuals suffer with psoriasis. Rosacea is a common skin ailment affecting 16 million individuals in the United States. More than 9,500 people in the United States were diagnosed with skin cancer every day.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Region is projected to Offer the Largest Opportunity for Dermatology CRO?
With over 10.4% projected growth rate, Dermatology CRO revenue is expected to grow at fastest pace in North America, during 2022 to 2032. This is due to a number of factors, including an aging population, increased awareness of skin conditions, and the development of new treatments. The CRO industry is growing rapidly, and the dermatology segment is expected to experience strong growth in the next few years.
Country-wise Analysis
Which Country Lies at the Centerstage for Dermatology CRO Revenue?
US leads the global revenues of Dermatology CRO market. This is attributed to the high frequency of skin problems, demographic variety, ease of recruiting and retaining patients, and an improved regulatory environment. Furthermore, market development is aided by favourable government initiatives. In February 2018, the Central Drugs Standard Control Organization (CDSCO) published new standards that are intended to reduce the time it takes to gain clearance from almost 30 to 60 days.
North America grabbed a highest dermatology CRO market share in 2021 due to the largest number of trials done and outsourced in the region. The increased government support for R&D activities through grants and money to research institutes and enterprises has further supported the expansion of this regional industry. In 2018, the US government, for example, spent US$ 194.2 Bn on medical and health research and development.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Why Clinical Dermatology CRO Remains the Faster Revenue Generating Segment?
Clinical dermatology CRO is the fastest revenue generating segment because it offers a wide range of services that can be customized to meet the specific needs of each client. This allows for quick turnaround times and efficient project management, which results in increased profits for the client. Additionally, the dermatology market is growing rapidly, providing opportunities for continued growth and expansion. Increasing prevalence of skin diseases, especially in case of psoriasis, is expected to propel clinical dermatology CRO segment.
How Has COVID-19 Impacted Revenue Generation from Dermatology CRO?
The necessity of virtual trials and the utilisation of technology and software solutions has been underlined by the COVID-19 pandemic. The increased use of machine learning-based platforms, artificial intelligence, and creative trial designs is projected to change the dermatological CRO landscape in the next years.
Biopharmaceutical and pharmaceutical investments in innovative and revolutionary therapies, such as regenerative medicine, and drug development services, are driving R&D activities. Experts and skills in a range of therapeutic disciplines are still needed by sponsors.
The impact of COVID-19 on Dermatology CRO was largely observed through the growing awareness of skin disorders, a high need for speedy diagnosis, and an increase in the frequency of skin cancer and other skin maladies.
Competitive Analysis
According to the market research analysis, partnerships and expansion have been the prominent development in Dermatology CRO market in recent years. IQVIA HOLDINGS INC., Covance Inc., Pharmaceutical Product Development, LLC (PPD), Parexel International Corporation, Charles River Laboratories International, Inc., Icon, Plc, Medidata Solutions, Inc., Syneos Health, Pharmaron, GVK Biosciences Private Limited, Wuxi AppTec, MEDPACE HOLDINGS, INC., PRA Health Sciences, CTI Clinical Trial & Consulting, Bioskin, Proinnovera, Biorasi, Javara, TFS are the prominent providers of Dermatology CRO services.
Some of the recent developments of key Dermatology CRO providers are as follows:
- In 2021 Thermo Fisher signed a binding deal to buy PPD for US$ 17.4 Bn. This purchase will greatly strengthen Thermo Fisher's position in the clinical research services market, particularly in the early phase clinical trials business. In addition to strengthening their services, healthcare contract research businesses are aiming to provide their services on a worldwide basis.
- In February 2021, Icon plc signed a binding deal to buy PRA Health Sciences for a valuation of around US$ 12 Bn. Customers will benefit from the merged firm because of the enhanced geographic, functional, and therapeutic scale.
- In October 2019, Parexel strengthened its ties with the Society for Clinical Research Sites (SCRS), to safeguard the interests of clinical research sites. The company implemented many significant initiatives as a Site Engagement Partner targeted at enhancing the patient experience in clinical trials.
Similarly, recent developments related to companies offering Dermatology CRO have been tracked by the team at Fact.MR, which are available in the full report.
Dermatology CRO Market Report Scope
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | US$ Bn for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania and MEA |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, U.K., France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Turkey, South Africa, GCC Countries |
| Key Market Segments Covered | Service, Product Type, End-user, Region |
| Key Companies Profiled | IQVIA HOLDINGS INC.; Covance Inc.; Pharmaceutical Product Development, LLC (PPD); Parexel International Corporation; Charles River Laboratories International, Inc.; Icon, Plc; Medidata Solutions, Inc.; Syneos Health; Pharmaron; GVK Biosciences Private Limited; Wuxi AppTec; MEDPACE HOLDINGS, INC.; PRA Health Sciences; CTI Clinical Trial & Consulting; Bioskin; Proinnovera; Biorasi; Javara; TFS |
| Pricing | Available upon Request |
Market Segments Covered in Dermatology CRO Industry Analysis
-
By Type :
- Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Preclinical
- Drug Discovery
-
By Service :
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient and Site Recruitment
- Technology
- Other Services
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Key Success Factors
- 6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type
- 8.1. Drug Discovery
- 8.1.1. Target Validation
- 8.1.2. Lead Identification
- 8.1.3. Lead Optimization
- 8.2. Clinical
- 8.2.1. Phase I
- 8.2.2. Phase II
- 8.2.3. Phase III
- 8.2.4. Phase IV
- 8.3. Pre-clinical
- 8.1. Drug Discovery
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Service
- 9.1. Project Management/Clinical Supply Management
- 9.2. Data Management
- 9.3. Regulatory/Medical Affairs
- 9.4. Medical Writing
- 9.5. Clinical Monitoring
- 9.6. Quality Management/Assurance
- 9.7. Bio-statistics
- 9.8. Investigator Payments
- 9.9. Laboratory
- 9.10. Patient and Site Recruitment
- 9.11. Technology
- 9.12. Other Services
- 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Europe
- 10.4. Asia Pacific
- 10.5. Middle East and Africa (MEA)
- 11. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 12. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 13. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 14. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 16. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. IQVIA HOLDINGS INC.
- 18.2. Covance Inc
- 18.3. Pharmaceutical Product Development, LLC
- 18.4. Parexel International Corporation
- 18.5. Charles River Laboratories International, Inc.
- 18.6. Icon, Plc
- 18.7. Medidata Solutions, Inc.
- 18.8. Syneos Health
- 18.9. Pharmaron
- 18.10. GVK Biosciences Private Limited
- 18.11. Wuxi AppTec
- 18.12. MEDPACE HOLDINGS, INC.
- 18.13. PRA Health Sciences
- 18.14. CTI Clinical Trial & Consulting
- 18.15. Bioskin
- 18.16. Proinnovera
- 18.17. Biorasi
- 18.18. Javara
- 18.19. TFS
- 19. Assumptions and Acronyms Used
- 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn), By Type, 2017 to 2021
Table 2: Global Market Value (US$ Mn), By Type, 2022 to 2032
Table 3: Global Market Value (US$ Mn), By Service, 2017 to 2021
Table 4: Global Market Value (US$ Mn), By Service, 2022 to 2032
Table 5: Global Market, By Region, 2017 to 2021
Table 6: Global Market, By Region, 2022 to 2032
Table 7: North America Market Value (US$ Mn), By Type, 2017 to 2021
Table 8: North America Market Value (US$ Mn), By Type, 2022 to 2032
Table 9: North America Market Value (US$ Mn), By Service, 2017 to 2021
Table 10: North America Market Value (US$ Mn), By Service, 2022 to 2032
Table 11: North America Market, By Country, 2017 to 2021
Table 12: North America Market, By Country, 2022 to 2032
Table 13: Latin America Market Value (US$ Mn), By Type, 2017 to 2021
Table 14: Latin America Market Value (US$ Mn), By Type, 2022 to 2032
Table 15: Latin America Market Value (US$ Mn), By Service, 2017 to 2021
Table 16: Latin America Market Value (US$ Mn), By Service, 2022 to 2032
Table 17: Latin America Market, By Country, 2017 to 2021
Table 18: Latin America Market, By Country, 2022 to 2032
Table 19: Europe Market Value (US$ Mn), By Type, 2017 to 2021
Table 20: Europe Market Value (US$ Mn), By Type, 2022 to 2032
Table 21: Europe Market Value (US$ Mn), By Service, 2017 to 2021
Table 22: Europe Market Value (US$ Mn), By Service, 2022 to 2032
Table 23: Europe Market, By Country, 2017 to 2021
Table 24: Europe Market, By Country, 2022 to 2032
Table 25: Asia Pacific Market Value (US$ Mn), By Type, 2017 to 2021
Table 26: Asia Pacific Market Value (US$ Mn), By Type, 2022 to 2032
Table 27: Asia Pacific Market Value (US$ Mn), By Service, 2017 to 2021
Table 28: Asia Pacific Market Value (US$ Mn), By Service, 2022 to 2032
Table 29: Asia Pacific Market, By Country, 2017 to 2021
Table 30: Asia Pacific Market, By Country, 2022 to 2032
Table 31: MEA Market Value (US$ Mn), By Type, 2017 to 2021
Table 32: MEA Market Value (US$ Mn), By Type, 2022 to 2032
Table 33: MEA Market Value (US$ Mn), By Service, 2017 to 2021
Table 34: MEA Market Value (US$ Mn), By Service, 2022 to 2032
Table 35: MEA Market, By Country, 2017 to 2021
Table 36: MEA Market, By Country, 2022 to 2032
Table 37: Global Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 38: Global Market Incremental $ Opportunity, By Service, 2022 to 2032
Table 39: Global Market Incremental $ Opportunity, By Region, 2022 to 2032
Table 40: North America Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 41: North America Market Incremental $ Opportunity, By Service, 2022 to 2032
Table 42: North America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 43: Latin America Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 44: Latin America Market Incremental $ Opportunity, By Service, 2022 to 2032
Table 45: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 46: Europe Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 47: Europe Market Incremental $ Opportunity, By Service, 2022 to 2032
Table 48: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 49: Asia Pacific Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 50: Asia Pacific Market Incremental $ Opportunity, By Service, 2022 to 2032
Table 51: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 52: MEA Market Incremental $ Opportunity, By Type, 2017 to 2021
Table 53: MEA Market Incremental $ Opportunity, By Service, 2022 to 2032
Table 54: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ Mn
Figure 3: Global Market Share, By Type, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Type – 2022 to 2032
Figure 5: Global Market Attractiveness Index, By Type – 2022 to 2032
Figure 6: Global Market Share, By Service, 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By Service – 2022 to 2032
Figure 8: Global Market Attractiveness Index, By Service – 2022 to 2032
Figure 9: Global Market Share, By Region, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Region – 2022 to 2032
Figure 11: Global Market Attractiveness Index, By Region – 2022 to 2032
Figure 12: North America Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 13: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 14: North America Market Share, By Type, 2022 & 2032
Figure 15: North America Market Y-o-Y Growth Projections, By Type – 2022 to 2032
Figure 16: North America Market Attractiveness Index, By Type – 2022 to 2032
Figure 17: North America Market Share, By Service, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Projections, By Service – 2022 to 2032
Figure 19: North America Market Attractiveness Index, By Service – 2022 to 2032
Figure 20: North America Market Share, By Country, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 22: North America Market Attractiveness Index, By Country – 2022 to 2032
Figure 23: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 24: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 25: Latin America Market Share, By Type, 2022 & 2032
Figure 26: Latin America Market Y-o-Y Growth Projections, By Type – 2022 to 2032
Figure 27: Latin America Market Attractiveness Index, By Type – 2022 to 2032
Figure 28: Latin America Market Share, By Service, 2022 & 2032
Figure 29: Latin America Market Y-o-Y Growth Projections, By Service – 2022 to 2032
Figure 30: Latin America Market Attractiveness Index, By Service – 2022 to 2032
Figure 31: Latin America Market Share, By Country, 2022 & 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 33: Latin America Market Attractiveness Index, By Country – 2022 to 2032
Figure 34: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 35: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 36: Europe Market Share, By Type, 2022 & 2032
Figure 37: Europe Market Y-o-Y Growth Projections, By Type – 2022 to 2032
Figure 38: Europe Market Attractiveness Index, By Type – 2022 to 2032
Figure 39: Europe Market Share, By Service, 2022 & 2032
Figure 40: Europe Market Y-o-Y Growth Projections, By Service – 2022 to 2032
Figure 41: Europe Market Attractiveness Index, By Service – 2022 to 2032
Figure 42: Europe Market Share, By Country, 2022 & 2032
Figure 43: Europe Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 44: Europe Market Attractiveness Index, By Country – 2022 to 2032
Figure 45: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 46: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 47: MEA Market Share, By Type, 2022 & 2032
Figure 48: MEA Market Y-o-Y Growth Projections, By Type – 2022 to 2032
Figure 49: MEA Market Attractiveness Index, By Type – 2022 to 2032
Figure 50: MEA Market Share, By Service, 2022 & 2032
Figure 51: MEA Market Y-o-Y Growth Projections, By Service – 2022 to 2032
Figure 52: MEA Market Attractiveness Index, By Service – 2022 to 2032
Figure 53: MEA Market Share, By Country, 2022 & 2032
Figure 54: MEA Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 55: MEA Market Attractiveness Index, By Country – 2022 to 2032
Figure 56: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2017 to 2032
Figure 57: Asia Pacific Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 58: Asia Pacific Market Share, By Type, 2022 & 2032
Figure 59: Asia Pacific Market Y-o-Y Growth Projections, By Type – 2022 to 2032
Figure 60: Asia Pacific Market Attractiveness Index, By Type – 2022 to 2032
Figure 61: Asia Pacific Market Share, By Service, 2022 & 2032
Figure 62: Asia Pacific Market Y-o-Y Growth Projections, By Service – 2022 to 2032
Figure 63: Asia Pacific Market Attractiveness Index, By Service – 2022 to 2032
Figure 64: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 65: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 66: Asia Pacific Market Attractiveness Index, By Country – 2022 to 2032
Figure 67: US Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 68: US Market Share, By Type, 2021
Figure 69: US Market Share, By Service, 2021
Figure 70: Canada Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 71: Canada Market Share, By Type, 2021
Figure 72: Canada Market Share, By Service, 2021
Figure 73: Brazil Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 74: Brazil Market Share, By Type, 2021
Figure 75: Brazil Market Share, By Service, 2021
Figure 76: Mexico Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 77: Mexico Market Share, By Type, 2021
Figure 78: Mexico Market Share, By Service, 2021
Figure 79: Germany Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 80: Germany Market Share, By Type, 2021
Figure 81: Germany Market Share, By Service, 2021
Figure 82: U.K. Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 83: U.K. Market Share, By Type, 2021
Figure 84: U.K. Market Share, By Service, 2021
Figure 85: France Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 86: France Market Share, By Type, 2021
Figure 87: France Market Share, By Service, 2021
Figure 88: Italy Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 89: Italy Market Share, By Type, 2021
Figure 90: Italy Market Share, By Service, 2021
Figure 91: BENELUX Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 92: BENELUX Market Share, By Type, 2021
Figure 93: BENELUX Market Share, By Service, 2021
Figure 94: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 95: Nordic Countries Market Share, By Type, 2021
Figure 96: Nordic Countries Market Share, By Service, 2021
Figure 97: China Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 98: China Market Share, By Type, 2021
Figure 99: China Market Share, By Service, 2021
Figure 100: Japan Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 101: Japan Market Share, By Type, 2021
Figure 102: Japan Market Share, By Service, 2021
Figure 103: South Korea Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 104: South Korea Market Share, By Type, 2021
Figure 105: South Korea Market Share, By Service, 2021
Figure 106: GCC Countries Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 107: GCC Countries Market Share, By Type, 2021
Figure 108: GCC Countries Market Share, By Service, 2021
Figure 109: South Africa Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 110: South Africa Market Share, By Type, 2021
Figure 111: South Africa Market Share, By Service, 2021
Figure 112: Turkey Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 113: Turkey Market Share, By Type, 2021
Figure 114: Turkey Market Share, By Service, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the current worth of the Dermatology CRO market?
The global dermatology CRO market is worth more than US$ 4 Billion at present.
What is the sales forecast for Dermatology CRO?
Value of Dermatology CRO are projected to increase at a CAGR of around 9.1% during 2022-2032.
What was the last 5 year’s market CAGR?
Value of Dermatology CRO increased at a CAGR of around 7.8% during 2017-2021.
What is a key trend shaping the growth of the market for Dermatology CRO?
One of the key trends in Dermatology CRO market includes that their providers have been expanding their geographical footprint.
What are the factors driving the revenue for Dermatology CRO market?
Growing awareness of skin disorders, a high need for speedy diagnosis, and an increase in the frequency of skin cancer and other skin maladies are propelling the dermatological CRO industry ahead.
Which are the top 5 countries driving demand for Dermatology CRO?
Top 5 countries driving demand for Dermatology CRO are the U.S., U.K., China, Japan and South Korea.
What is the outlook for the market in US?
US will accounted for over 33% of global Dermatology CRO demand in 2032 with a CAGR of 9.4%.
At what percentage is sales of Dermatology CRO going to register growth from 2022 to 2032?
The market for Dermatology CRO is projected to expand at a CAGR of around 9.1% during 2022 – 2032 with the global market size of US$ 12.8 Billion
What do statistics for South Korea and Japan reveal?
While the market in South Korea is expected to grow at nearly 8.9%, the market in Japan is projected to register a CAGR of nearly 12.5% during 2022-2032.
Dermatology CRO Market